Top compounds associated with response to MYRIP


Feature Type Standardized
Nominal ANOVA
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.059 0.06
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.067 0.06
mRNA BRD-K29313308 CTRPv2 pan-cancer AAC 0.069 0.06
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.066 0.06
mRNA lapatinib CCLE pan-cancer AAC 0.083 0.06
mRNA OSI-906 CTRPv2 pan-cancer AAC 0.065 0.06
mRNA MP470 GDSC1000 pan-cancer AAC 0.066 0.06
mRNA MK-0752 CTRPv2 pan-cancer AAC 0.07 0.06
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.062 0.07
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.066 0.07
Download CSV